Page last updated: 2024-09-03

1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and 6-bromoindirubin-3'-oxime

1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine has been researched along with 6-bromoindirubin-3'-oxime in 1 studies

Compound Research Comparison

Studies
(1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine)
Trials
(1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine)
Recent Studies (post-2010)
(1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine)
Studies
(6-bromoindirubin-3'-oxime)
Trials
(6-bromoindirubin-3'-oxime)
Recent Studies (post-2010) (6-bromoindirubin-3'-oxime)
530151710114

Protein Interaction Comparison

ProteinTaxonomy1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine (IC50)6-bromoindirubin-3'-oxime (IC50)
SUMO1/sentrin specific peptidase 7Homo sapiens (human)5.6
Glycogen synthase kinase-3 beta Sus scrofa (pig)0.005
[Tau protein] kinase Sus scrofa (pig)0.005
caspase-3 isoform a preproproteinHomo sapiens (human)64.3
matrix metalloproteinase-14 preproproteinHomo sapiens (human)5.335
melanocortin receptor 4Homo sapiens (human)6.37
Aurora kinase AHomo sapiens (human)0.6
Casein kinase I isoform alphaSus scrofa (pig)1.2
Cyclin-T1Homo sapiens (human)0.45
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.32
Cyclin-dependent kinase 1Homo sapiens (human)0.3117
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)2.0333
Cyclin-dependent kinase 4Homo sapiens (human)0.527
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.3075
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)0.6
Cyclin-A2Homo sapiens (human)0.069
G1/S-specific cyclin-D1Homo sapiens (human)0.527
G1/S-specific cyclin-E1Homo sapiens (human)0.014
Cyclin-dependent kinase 2Homo sapiens (human)0.0415
Dual specificity protein kinase CLK1Homo sapiens (human)2.1
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.062
Glycogen synthase kinase-3 betaHomo sapiens (human)0.3298
Cyclin-dependent kinase 7Homo sapiens (human)3.5
Cyclin-dependent kinase 9Homo sapiens (human)0.45
Cyclin-HHomo sapiens (human)3.5
CDK-activating kinase assembly factor MAT1Homo sapiens (human)3.5
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.078
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.052
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.0746
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)1.5
Dual specificity tyrosine-phosphorylation-regulated kinase 1ARattus norvegicus (Norway rat)1.11
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.32
Dual specificity tyrosine-phosphorylation-regulated kinase 2Homo sapiens (human)2.1
Aurora kinase BHomo sapiens (human)0.9
Bile acid receptorHomo sapiens (human)3.4
Aurora kinase CHomo sapiens (human)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1

Other Studies

1 other study(ies) available for 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and 6-bromoindirubin-3'-oxime

ArticleYear
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009